Abstract
Get full access to this article
View all access options for this article.
References
1.
Tang
S.
,
Cheng
C.
,
Tse
K.
,
Li
F.
,
Choy
B.
,
Chan
T.
CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans. Am J Nephrol 2001 ; 21 : 502 –6 .
2.
Melgosa
M.
,
Espinazo
O.
,
Alonso
A.
,
Garcia Perea
A.
,
Navaro
M.
Dialysis-associated Alcaligenes xylosoxidans peritonitis: a pediatric case. Perit Dial Int 2004 ; 24 : 72 –5 .
3.
El-Shahawy
M.
,
Kim
D.
,
Gadallah
M.F.
Peritoneal dialysis-associated peritonitis caused by Alcaligenes xylosoxidans. Am J Nephrol 1998 ; 18 : 452 –5 .
4.
Ingra-Sieman
Y.
,
Chmel
H.
,
Cobbs
C.
Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol 1980 ; 11 : 141 –5 .
5.
Reveredy
M.
,
Freney
J.
,
Fleurette
J.
,
Coulet
M.
,
Surgot
M.
,
Marmet
D.
Nosocomial colonization and infection by Achromobacter xylosoxidans . J Clin Microbiol 1984 ; 19 : 140 –3 .
6.
Morrison
A.
,
Boyce
K.
Peritonitis caused by Alcaligenes xylosoxidans : case report and review of the literature. J Clin Microbiol 1986 ; 24 : 879 –81 .
7.
Haqqie
S.
,
Roth
M.
,
Bailie
G.
Unsuccessful treatment of CAPD peritonitis caused by Alcaligenes xylosoxidans subsp. denitrificans. Ren Fail 1995 ; 17 : 611 –14 .
8.
Piraino
B.
,
Bailie
G.R.
,
Bernardini
J.
,
Boeschoten
E.
,
Gupta
A.
,
Holmes
C.
Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005 ; 25 : 107 –31 .
9.
Schaefer
F.
,
Klaus
G.
,
Muller-Wiefel
D.
,
Mehls
O.
Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Dialysis Study Group (MEPPS). J Am Soc Nephrol 1999 ; 10 : 136 –45 .
10.
Low
C.
,
Gopalakrishna
K.
,
Lye
W.
Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2000 ; 11 : 1117 –21 .